NCT03535519View on ClinicalTrials.gov

Rheumatoid Arthritis Response to Methotrexate

UnknownOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Methotrexate

standard of care treatment with methotrexate

Trial Locations (1)

28007

RECRUITING

Hospital General Universitario Gregorio Marañón, Madrid

Sponsors

Collaborators (1)

Nordic Pharma SAS

All Listed Sponsors

collaborator

Nordic Pharma SAS

INDUSTRY

lead

Juan Carlos Nieto

OTHER

NCT03535519 - Rheumatoid Arthritis Response to Methotrexate | Biotech Hunter | Biotech Hunter